CAS 953778-63-7

"(R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide "

Description:

The chemical substance known as (R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide, with the CAS number 953778-63-7, is a synthetic organic compound characterized by its complex structure, which includes a cyclopropyl group, a pyridine moiety, and a trifluoroethoxy substituent. This compound is likely to exhibit specific pharmacological properties due to its unique arrangement of functional groups, which may influence its interactions with biological targets. The presence of the trifluoroethoxy group suggests potential lipophilicity, which can affect its solubility and permeability in biological systems. Additionally, the chirality indicated by the (R) configuration may play a crucial role in its biological activity, as enantiomers can exhibit different effects in pharmacological contexts. Overall, this compound may be of interest in medicinal chemistry, particularly in the development of new therapeutic agents, although detailed studies would be necessary to elucidate its specific properties and potential applications.

Formula: C₂₀H₂₁F₃N₂O₂

Synonyms:

• (R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamid
• Pregnane X receptor,TTA-A2,neurological diseases,T-type calcium channel,Inhibitor,Ca2+ channels,Ca channels,Electrocorticogram,TTAA2,sleep disorders,TTA-A-2,inhibit,TTA A2,Epilepsy,Calcium Channel
• Benzeneacetamide, 4-cyclopropyl-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]-
• "(R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide "
• TTA-A2
• 2-(4-cyclopropylphenyl)-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide

TTA-A2

CAS: 953778-63-7

TTA-A2

Purity: ≥98%

Molecular weight: 378.39g/mol

Ref: 54-BUP08085

TTA-A2

CAS: 953778-63-7

TTA-A2: T-type calcium channel blocker; anticonvulsant targeting Cav3.1, Cav3.2; IC50 of 89/92 nM; potential for treating neurological conditions.

Formula: C₂₀H₂₁F₃N₂O₂

Purity: 99.5% - 99.9%

Color and Shape: Solid

Molecular weight: 378.39

Ref: TM-T8944

TTA-A2

CAS: 953778-63-7

TTA-A2 is a t-type calcium channel blocker. It has been shown to reduce locomotor activity and activate lymphatic vessels in rats. TTA-A2 is also a potential drug target for metabolic disorders, such as obesity, diabetes, and hypertension. TTA-A2 has been shown to have anti-inflammatory effects on the bowel that may be due to its ability to inhibit intracellular calcium concentration. Other studies have shown that TTA-A2 can be used for the treatment of bowel disease and inflammatory bowel disease. In addition, there are no side effect profiles associated with TTA-A2.

Formula: C₂₀H₂₁F₃N₂O₂

Purity: Min. 95%

Molecular weight: 378.4 g/mol

Ref: 3D-DNB77863